How does aprepitant actually stop nausea and vomiting?
Aprepitant blocks substance P, a brain chemical that triggers the nausea reflex. It crosses the blood-brain barrier and occupies NK1 receptors for 3+ days, preventing chemo or surgery signals from making you feel sick [9].
Chemotherapy and anesthesia trigger nausea by releasing substance P in your brain's vomiting center. Aprepitant is a selective NK1 receptor antagonist—it acts like a lock that blocks substance P from turning on the nausea switch. Clinical trials show 70–90% of patients on aprepitant plus a 5-HT3 blocker (like ondansetron) stay completely nausea-free for 3+ days after high-dose chemo [8].
Your brain has two main nausea pathways: one uses serotonin (5-HT3), the other uses substance P (NK1). Older anti-nausea drugs only block serotonin. Aprepitant blocks the substance P pathway, which is why combining it with ondansetron (a 5-HT3 blocker) works so much better than either drug alone. Think of it as closing two different doors to the nausea room [1].
The trade-off is timing. Aprepitant takes 2–4 hours to reach peak brain levels, so it works best when given before chemo or surgery starts. If you're already vomiting, the IV form (Cinvanti, 130 mg) works faster—30 minutes—but costs more upfront. For post-surgery nausea, a single 40 mg dose within 3 hours of waking up prevents nausea in 50–65% of patients [5][9].
Ask your oncologist or surgeon: 'Should I take aprepitant before my chemo/surgery, or will you give me the IV form in the hospital?' Timing matters. Pre-treatment with the capsule is cheaper; IV rescue therapy is faster if nausea breaks through [9].